HT1079
Weigert′s Iron Hematoxylin Set
Set
Synonym(s):
Weigert’s iron hematoxylin solution
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Quality Level
form
solution
shelf life
Expiry date on the label.
IVD
for in vitro diagnostic use
technique(s)
microbe id | staining: suitable
application(s)
hematology
histology
storage temp.
room temp
Application
Recommended in lengthy or acidic stain procedures. Resists decolorization better than aluminum based hematoxylin formulations.
Other Notes
Weigert′s iron hematoxylin solution set consists of HT107 Part A and HT109 Part B.
signalword
Danger
hcodes
Hazard Classifications
Eye Irrit. 2 - Flam. Liq. 2 - Met. Corr. 1
Storage Class
3 - Flammable liquids
flash_point_f
60.0 °F
flash_point_c
15.55 °C
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Related Content
Eleni Tseliou et al.
PloS one, 11(1), e0144523-e0144523 (2016-01-20)
Single-vessel, intracoronary infusion of stem cells under stop-flow conditions has proven safe but achieves only limited myocardial coverage. Continuous flow intracoronary delivery to one or more coronary vessels may achieve broader coverage for treating cardiomyopathy, but has not been investigated.
Hekmat B Khoukaz et al.
Arteriosclerosis, thrombosis, and vascular biology, 40(6), 1479-1490 (2020-04-10)
Enhanced expression of PAI-1 (plasminogen activator inhibitor-1) has been implicated in atherosclerosis formation in humans with obesity and metabolic syndrome. However, little is known about the effects of pharmacological targeting of PAI-1 on atherogenesis. This study examined the effects of
Lucia Kořínková et al.
Journal of molecular endocrinology, 64(2), 77-90 (2019-12-20)
Lack of leptin production in ob/ob mice results in obesity and prediabetes that could be partly reversed by leptin supplementation. In the hypothalamus, leptin supports the production of prolactin-releasing peptide (PrRP), an anorexigenic neuropeptide synthesized and active in the brain.